Testing and Linkage to Care for Injecting Drug Users in Kenya (TLCIDU Kenya)

Phase:Open Label
Principal Investigator(s):Ann Kurth & John Lizcano
Objective:This study will leverage a historic decision in Kenya to launch needle exchange programs and related services for the most-at-risk population. Investigators will seek out IDUs, deliver rapid HIV testing, point of care CD4 count and link to ART using peer case managers, and evaluate community viral load impact.
Prevention Option(s):Treatment U=U
Study Design:Controlled, Open label, Randomized
Official Code: NCT01557998
Trial Sponsors: New York University School of Medicine
Start Date
End Date
March 31, 2012
April 30, 2015
Age range: 18 Years ↔ any
Population:Cisgender Men, Cisgender Women, Injecting drug users, People Living with HIV